Female-Owned Biotech Startup Tiamat Sciences Raises $3 Million To Manufacture Plant-Based Biomolecules
Female-Owned Biotech Startup Tiamat Sciences Raises $3 Million To Manufacture Plant-Based Biomolecules
11/24/21, 11:01 AM
Location
durhamMoney raised
$3 million
Round Type
seed
Biotechnology startup Tiamat Sciences today announced its $3 million seed financing round led by Silicon Valley venture capital firm True Ventures with participation from Social Impact Capital and Cantos. Tiamat Sciences manufactures animal-free proteins using a proprietary plant molecular farming platform. By replacing costly bioreactors with plants, the company produces key reagents for biotechnology companies at a fraction of the cost.
Company Info
Location
durham, north carolina, united states
Additional Info
About Tiamat SciencesTiamat Sciences is reinventing recombinant proteins to fuel the next generation of biotech companies across cellular agriculture, regenerative medicine, vaccine production, and more. By using the power of plants, Tiamat provides animal-free recombinant proteins at the fraction of their cost with a reduced carbon footprint. The team is on track to become the fastest growing supplier of recombinant proteins.